Áttétes emlőrák: vizsgálatok itt: Norvégia

In Norvégia 6 Also abroad 610

6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
Where
Bergen, Oslo, Tromsø, Trondheim
Életkor
18 év and over
People
345 worldwide
Run by
Vastra Gotaland Region
See details and how to joinNCT05377047
1. fázisTaking people
A First-in-Human phase 1, open-label, two-stage, randomized trial to assess the safety, tolerability, and biodistribution of [177Lu]Lu-ABY-271 in tumors and critical organs in subjects with HER2-positive metastatic breast cancer
Where
Oslo
Életkor
18 év and over
People
30 worldwide
Run by
Affibody AB
See details and how to join2024-518360-13-00 · EU 2024-518360-13-00
No phaseTaking people
DESTINY Breast Respond HER2-(Ultra)Low Europe
Where
Bodø, Drammen, Kristiansand, Skien, Tromsø
Életkor
18 év and over
People
2295 worldwide
Run by
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
See details and how to joinNCT05945732
4. fázisTaking people
IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs – a pragmatic randomized-controlled trial (IMPORTANT trial)
Where
Lorenskog
Életkor
65 év and over
People
495 worldwide
Run by
Region Oerebro Laen
See details and how to join2023-506620-87-00 · EU 2023-506620-87-00
3. fázisTaking people
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Where
Oslo
Életkor
70 év and over
People
495 worldwide
Run by
Region Örebro County
See details and how to joinNCT06044623
2. fázisTaking people
Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
Where
Lørenskog
Életkor
18 év and over
People
60
Run by
University Hospital, Akershus
See details and how to joinNCT05732051